Skip to main content


Hybrid Event
The Science and Business of AI-Driven Drug Discovery
25 Jun 2024



June 25, 2024 | 5-7 PM ET

The Academy community is invited to use promo code NYAS@CURE for $5.00 off entry.

Join experts in the fields of artificial intelligence and pharmaceuticals to explore the transformative role of AI in drug discovery. The panelists will share their insights on how machine learning algorithms are revolutionizing the drug development process by accelerating target identification, predicting compound interactions, and optimizing clinical trial designs. Attendees will gain valuable perspectives on the potential for AI to drive personalized medicine and tackle rare diseases, among other potential applications.


Maria Luisa Pineda, Co-Founder and CEO of Envisagenics

Grant Mitchell, Co-Founder and CEO of Every Cure

Andrea Califano, Chair, Dept of Systems Biology, Columbia University and Chan Zuckerberg Biohub New York President


Opening Remarks from Nicholas B. Dirks PhD, President and CEO , The New York Academy of Sciences

Moderator, Seema Kumar, CEO of Cure


The event is open for registration.